Stem Cell Therapy in Progressive Liver Fibrosis: Eine umfassende Rezension
Liver fibrosis is a chronic condition characterized by the excessive accumulation of scar tissue in the liver, Dies führt zu einer Beeinträchtigung der Leberfunktion und möglicherweise lebensbedrohlichen Komplikationen. Stem cell therapy has emerged as a promising approach for treating liver fibrosis by harnessing the regenerative potential of stem cells. This review provides a comprehensive overview of the current understanding of stem cell therapy in progressive liver fibrosis.
Etiology and Pathogenesis of Liver Fibrosis
Liver fibrosis is primarily caused by chronic liver injury, which can result from various etiologies such as viral infections, Alkoholmissbrauch, nichtalkoholische Fettlebererkrankung, und Autoimmunerkrankungen. Hepatic stellate cells (HSCs) are the primary mediators of fibrosis. Upon activation, HSCs undergo a phenotypic transformation into myofibroblasts, which produce and secrete excessive extracellular matrix (ECM) Komponenten, leading to the formation of fibrotic scars.
Rolle von Stammzellen bei der Leberregeneration
Stem cells possess the ability to self-renew and differentiate into various cell types. In der Leber, stem cells contribute to liver regeneration and repair. Two main types of stem cells involved in liver regeneration are mesenchymal stem cells (MSCs) and hepatic stem cells (HSCs). MSCs can differentiate into hepatocytes, Cholangiozyten, and other liver cell types, while HSCs give rise to hepatocytes.
Mesenchymal Stem Cells for Fibrosis Treatment
MSCs have shown promise in treating liver fibrosis. They can inhibit HSC activation and proliferation, fördern die Regeneration der Hepatozyten, und modulieren die Immunantwort. Preclinical studies have demonstrated that MSCs can reduce fibrosis and improve liver function in animal models of liver disease. Clinical trials are currently underway to evaluate the safety and efficacy of MSC therapy in patients with liver fibrosis.
Interessiert daran, zu erfahren, ob aktuelle klinische Programme vorliegen, Forschungsentwicklungen, oder neue therapeutische Ansätze können für Ihre Situation relevant sein?
Nur Bildungs- und Forschungsinformationen. Individuelle medizinische Entscheidungen sollten in Absprache mit qualifiziertem medizinischem Fachpersonal getroffen werden.
